Mattis Dementia Rating Scale 2: Screening for MCI and Dementia
Identifying patients at higher risk of developing dementia is important. The usefulness of the Mattis Dementia Rating scale-Second Edition (MDRS-2) to detect and differentiate between patients with amnestic mild cognitive impairment (A-MCI), Parkinson’s disease and MCI (PD-MCI), PD with dementia (PD...
Gespeichert in:
| Veröffentlicht in: | American journal of Alzheimer's disease and other dementias 2011-08, Vol.26 (5), p.389-398 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 398 |
|---|---|
| container_issue | 5 |
| container_start_page | 389 |
| container_title | American journal of Alzheimer's disease and other dementias |
| container_volume | 26 |
| creator | Matteau, Evelyne Dupré, Nicolas Langlois, Mélanie Jean, Léonie Thivierge, Stéphanie Provencher, Pierre Simard, Martine |
| description | Identifying patients at higher risk of developing dementia is important. The usefulness of the Mattis Dementia Rating scale-Second Edition (MDRS-2) to detect and differentiate between patients with amnestic mild cognitive impairment (A-MCI), Parkinson’s disease and MCI (PD-MCI), PD with dementia (PDD), and Alzheimer’s disease (AD) was investigated. In all, 22 healthy controls (HC), 22 A-MCI, 22 PD-MCI, 16 PDD, and 22 AD patients were evaluated using an extensive neuropsychological battery, including the MDRS-2. The MDRS-2 total standardized score detected all groups of patients. The dementia groups performed worse than HC on the 5 MDRS-2 subscales. Alzheimer’s disease patients scored higher than PDD on MDRS-2 conceptualization and lower on memory. Healthy controls were better than PD-MCI on MDRS-2 initiation/perseveration and memory and better than A-MCI on memory. No difference was found between the MCI groups. The MDRS-2 is a suitable short scale for MCI and dementia screening but is not specific enough to differentiate between A-MCI and PD-MCI. |
| doi_str_mv | 10.1177/1533317511412046 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10845364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1533317511412046</sage_id><sourcerecordid>1367481759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-7862c7c164708b642d271494723e9dba7a685acf46bf7193b426b9ceca8752093</originalsourceid><addsrcrecordid>eNp9kUtLAzEUhYMotlb3rsrsdDOam2TyWInUJyiCj3XIpJk6ZR41mRH896a0FhV0lcD57uHccxE6BHwCIMQpZJRSEBkAA4IZ30JDUFSmRFDYjv8op0t9gPZCmGPMMinxLhoQ4EoAo0M0vjddV4bkwtWu6UqTPJqubGbJkzWVS8g-2ilMFdzB-h2hl6vL58lNevdwfTs5v0stFbJLheTECgucCSxzzsiURHvFBKFOTXMjDJeZsQXjeSFiwpwRnivrrJEiI1jRETpb-S76vHZTG7N4U-mFL2vjP3RrSv1TacpXPWvfNWDJMspZdDhaO_j2rXeh03UZrKsq07i2D1phzCkTSkby-F8SKBdMxtaWsfAKtb4NwbtikwiwXl5A_75AHBl_32Qz8FV5BNIVEMzM6Xnb-yY2-7fhJxqZiqw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1367481759</pqid></control><display><type>article</type><title>Mattis Dementia Rating Scale 2: Screening for MCI and Dementia</title><source>Sage Journals GOLD Open Access 2024</source><creator>Matteau, Evelyne ; Dupré, Nicolas ; Langlois, Mélanie ; Jean, Léonie ; Thivierge, Stéphanie ; Provencher, Pierre ; Simard, Martine</creator><creatorcontrib>Matteau, Evelyne ; Dupré, Nicolas ; Langlois, Mélanie ; Jean, Léonie ; Thivierge, Stéphanie ; Provencher, Pierre ; Simard, Martine</creatorcontrib><description>Identifying patients at higher risk of developing dementia is important. The usefulness of the Mattis Dementia Rating scale-Second Edition (MDRS-2) to detect and differentiate between patients with amnestic mild cognitive impairment (A-MCI), Parkinson’s disease and MCI (PD-MCI), PD with dementia (PDD), and Alzheimer’s disease (AD) was investigated. In all, 22 healthy controls (HC), 22 A-MCI, 22 PD-MCI, 16 PDD, and 22 AD patients were evaluated using an extensive neuropsychological battery, including the MDRS-2. The MDRS-2 total standardized score detected all groups of patients. The dementia groups performed worse than HC on the 5 MDRS-2 subscales. Alzheimer’s disease patients scored higher than PDD on MDRS-2 conceptualization and lower on memory. Healthy controls were better than PD-MCI on MDRS-2 initiation/perseveration and memory and better than A-MCI on memory. No difference was found between the MCI groups. The MDRS-2 is a suitable short scale for MCI and dementia screening but is not specific enough to differentiate between A-MCI and PD-MCI.</description><identifier>ISSN: 1533-3175</identifier><identifier>EISSN: 1938-2731</identifier><identifier>DOI: 10.1177/1533317511412046</identifier><identifier>PMID: 21697143</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Aged ; Alzheimer Disease - diagnosis ; Case-Control Studies ; Cognition Disorders - diagnosis ; Cross-Sectional Studies ; Current Topics in Research ; Dementia - diagnosis ; Female ; Humans ; Male ; Memory ; Memory Disorders - diagnosis ; Middle Aged ; Neuropsychological Tests - standards ; Severity of Illness Index</subject><ispartof>American journal of Alzheimer's disease and other dementias, 2011-08, Vol.26 (5), p.389-398</ispartof><rights>SAGE Publications 2011</rights><rights>SAGE Publications 2011 2011 SAGE Publications</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c378t-7862c7c164708b642d271494723e9dba7a685acf46bf7193b426b9ceca8752093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10845364/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10845364/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,21947,27834,27905,27906,44926,45314,53772,53774</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1533317511412046?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21697143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matteau, Evelyne</creatorcontrib><creatorcontrib>Dupré, Nicolas</creatorcontrib><creatorcontrib>Langlois, Mélanie</creatorcontrib><creatorcontrib>Jean, Léonie</creatorcontrib><creatorcontrib>Thivierge, Stéphanie</creatorcontrib><creatorcontrib>Provencher, Pierre</creatorcontrib><creatorcontrib>Simard, Martine</creatorcontrib><title>Mattis Dementia Rating Scale 2: Screening for MCI and Dementia</title><title>American journal of Alzheimer's disease and other dementias</title><addtitle>Am J Alzheimers Dis Other Demen</addtitle><description>Identifying patients at higher risk of developing dementia is important. The usefulness of the Mattis Dementia Rating scale-Second Edition (MDRS-2) to detect and differentiate between patients with amnestic mild cognitive impairment (A-MCI), Parkinson’s disease and MCI (PD-MCI), PD with dementia (PDD), and Alzheimer’s disease (AD) was investigated. In all, 22 healthy controls (HC), 22 A-MCI, 22 PD-MCI, 16 PDD, and 22 AD patients were evaluated using an extensive neuropsychological battery, including the MDRS-2. The MDRS-2 total standardized score detected all groups of patients. The dementia groups performed worse than HC on the 5 MDRS-2 subscales. Alzheimer’s disease patients scored higher than PDD on MDRS-2 conceptualization and lower on memory. Healthy controls were better than PD-MCI on MDRS-2 initiation/perseveration and memory and better than A-MCI on memory. No difference was found between the MCI groups. The MDRS-2 is a suitable short scale for MCI and dementia screening but is not specific enough to differentiate between A-MCI and PD-MCI.</description><subject>Aged</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Case-Control Studies</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cross-Sectional Studies</subject><subject>Current Topics in Research</subject><subject>Dementia - diagnosis</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Memory</subject><subject>Memory Disorders - diagnosis</subject><subject>Middle Aged</subject><subject>Neuropsychological Tests - standards</subject><subject>Severity of Illness Index</subject><issn>1533-3175</issn><issn>1938-2731</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtLAzEUhYMotlb3rsrsdDOam2TyWInUJyiCj3XIpJk6ZR41mRH896a0FhV0lcD57uHccxE6BHwCIMQpZJRSEBkAA4IZ30JDUFSmRFDYjv8op0t9gPZCmGPMMinxLhoQ4EoAo0M0vjddV4bkwtWu6UqTPJqubGbJkzWVS8g-2ilMFdzB-h2hl6vL58lNevdwfTs5v0stFbJLheTECgucCSxzzsiURHvFBKFOTXMjDJeZsQXjeSFiwpwRnivrrJEiI1jRETpb-S76vHZTG7N4U-mFL2vjP3RrSv1TacpXPWvfNWDJMspZdDhaO_j2rXeh03UZrKsq07i2D1phzCkTSkby-F8SKBdMxtaWsfAKtb4NwbtikwiwXl5A_75AHBl_32Qz8FV5BNIVEMzM6Xnb-yY2-7fhJxqZiqw</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>Matteau, Evelyne</creator><creator>Dupré, Nicolas</creator><creator>Langlois, Mélanie</creator><creator>Jean, Léonie</creator><creator>Thivierge, Stéphanie</creator><creator>Provencher, Pierre</creator><creator>Simard, Martine</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110801</creationdate><title>Mattis Dementia Rating Scale 2</title><author>Matteau, Evelyne ; Dupré, Nicolas ; Langlois, Mélanie ; Jean, Léonie ; Thivierge, Stéphanie ; Provencher, Pierre ; Simard, Martine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-7862c7c164708b642d271494723e9dba7a685acf46bf7193b426b9ceca8752093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Case-Control Studies</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cross-Sectional Studies</topic><topic>Current Topics in Research</topic><topic>Dementia - diagnosis</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Memory</topic><topic>Memory Disorders - diagnosis</topic><topic>Middle Aged</topic><topic>Neuropsychological Tests - standards</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matteau, Evelyne</creatorcontrib><creatorcontrib>Dupré, Nicolas</creatorcontrib><creatorcontrib>Langlois, Mélanie</creatorcontrib><creatorcontrib>Jean, Léonie</creatorcontrib><creatorcontrib>Thivierge, Stéphanie</creatorcontrib><creatorcontrib>Provencher, Pierre</creatorcontrib><creatorcontrib>Simard, Martine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of Alzheimer's disease and other dementias</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Matteau, Evelyne</au><au>Dupré, Nicolas</au><au>Langlois, Mélanie</au><au>Jean, Léonie</au><au>Thivierge, Stéphanie</au><au>Provencher, Pierre</au><au>Simard, Martine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mattis Dementia Rating Scale 2: Screening for MCI and Dementia</atitle><jtitle>American journal of Alzheimer's disease and other dementias</jtitle><addtitle>Am J Alzheimers Dis Other Demen</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>26</volume><issue>5</issue><spage>389</spage><epage>398</epage><pages>389-398</pages><issn>1533-3175</issn><eissn>1938-2731</eissn><abstract>Identifying patients at higher risk of developing dementia is important. The usefulness of the Mattis Dementia Rating scale-Second Edition (MDRS-2) to detect and differentiate between patients with amnestic mild cognitive impairment (A-MCI), Parkinson’s disease and MCI (PD-MCI), PD with dementia (PDD), and Alzheimer’s disease (AD) was investigated. In all, 22 healthy controls (HC), 22 A-MCI, 22 PD-MCI, 16 PDD, and 22 AD patients were evaluated using an extensive neuropsychological battery, including the MDRS-2. The MDRS-2 total standardized score detected all groups of patients. The dementia groups performed worse than HC on the 5 MDRS-2 subscales. Alzheimer’s disease patients scored higher than PDD on MDRS-2 conceptualization and lower on memory. Healthy controls were better than PD-MCI on MDRS-2 initiation/perseveration and memory and better than A-MCI on memory. No difference was found between the MCI groups. The MDRS-2 is a suitable short scale for MCI and dementia screening but is not specific enough to differentiate between A-MCI and PD-MCI.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>21697143</pmid><doi>10.1177/1533317511412046</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1533-3175 |
| ispartof | American journal of Alzheimer's disease and other dementias, 2011-08, Vol.26 (5), p.389-398 |
| issn | 1533-3175 1938-2731 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10845364 |
| source | Sage Journals GOLD Open Access 2024 |
| subjects | Aged Alzheimer Disease - diagnosis Case-Control Studies Cognition Disorders - diagnosis Cross-Sectional Studies Current Topics in Research Dementia - diagnosis Female Humans Male Memory Memory Disorders - diagnosis Middle Aged Neuropsychological Tests - standards Severity of Illness Index |
| title | Mattis Dementia Rating Scale 2: Screening for MCI and Dementia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T11%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mattis%20Dementia%20Rating%20Scale%202:%20Screening%20for%20MCI%20and%20Dementia&rft.jtitle=American%20journal%20of%20Alzheimer's%20disease%20and%20other%20dementias&rft.au=Matteau,%20Evelyne&rft.date=2011-08-01&rft.volume=26&rft.issue=5&rft.spage=389&rft.epage=398&rft.pages=389-398&rft.issn=1533-3175&rft.eissn=1938-2731&rft_id=info:doi/10.1177/1533317511412046&rft_dat=%3Cproquest_AFRWT%3E1367481759%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1367481759&rft_id=info:pmid/21697143&rft_sage_id=10.1177_1533317511412046&rfr_iscdi=true |